Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Immunoglobulin E as a Biomarker for the Overlap of Atopic Asthma and Chronic Obstructive Pulmonary Disease.

Hersh CP, Zacharia S, Prakash Arivu Chelvan R, Hayden LP, Mirtar A, Zarei S, Putcha N; COPDGene® Investigators.

Chronic Obstr Pulm Dis. 2020 Jan;7(1):1-12. doi: 10.15326/jcopdf.7.1.2019.0138.

2.

Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.

Paulin LM, Gassett AJ, Alexis NE, Kirwa K, Kanner RE, Peters S, Krishnan JA, Paine R 3rd, Dransfield M, Woodruff PG, Cooper CB, Barr RG, Comellas AP, Pirozzi CS, Han M, Hoffman EA, Martinez FJ, Woo H, Peng RD, Fawzy A, Putcha N, Breysse PN, Kaufman JD, Hansel NN; for SPIROMICS investigators.

JAMA Intern Med. 2019 Dec 9. doi: 10.1001/jamainternmed.2019.5498. [Epub ahead of print]

PMID:
31816012
3.

Relationship between Omega-3 and Omega-6 Fatty Acid Intake and COPD Morbidity.

Lemoine C, Brigham E, Woo H, Koch A, Hanson C, Romero K, Putcha N, McCormack M, Hansel N.

Ann Am Thorac Soc. 2019 Nov 21. doi: 10.1513/AnnalsATS.201910-740RL. [Epub ahead of print] No abstract available.

PMID:
31751155
4.

The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS.

Wells JM, Xing D, Viera L, Burkes RM, Wu Y, Bhatt SP, Dransfield MT, Couper DJ, O'Neal W, Hoffman EA, Gaggar A, Barjaktarevic I, Curtis JL, Labaki WW, Han MLK, Freeman CM, Putcha N, Schlange T, Blalock JE; SPIROMICS Investigators,.

Respir Res. 2019 Nov 12;20(1):254. doi: 10.1186/s12931-019-1230-8.

5.

COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.

Lowe KE, Regan EA, Anzueto A, Austin E, Austin JHM, Beaty TH, Benos PV, Benway CJ, Bhatt SP, Bleecker ER, Bodduluri S, Bon J, Boriek AM, Boueiz AR, Bowler RP, Budoff M, Casaburi R, Castaldi PJ, Charbonnier JP, Cho MH, Comellas A, Conrad D, Costa Davis C, Criner GJ, Curran-Everett D, Curtis JL, DeMeo DL, Diaz AA, Dransfield MT, Dy JG, Fawzy A, Fleming M, Flenaugh EL, Foreman MG, Fortis S, Gebrekristos H, Grant S, Grenier PA, Gu T, Gupta A, Han MK, Hanania NA, Hansel NN, Hayden LP, Hersh CP, Hobbs BD, Hoffman EA, Hogg JC, Hokanson JE, Hoth KF, Hsiao A, Humphries S, Jacobs K, Jacobson FL, Kazerooni EA, Kim V, Kim WJ, Kinney GL, Koegler H, Lutz SM, Lynch DA, MacIntye NR Jr, Make BJ, Marchetti N, Martinez FJ, Maselli DJ, Mathews AM, McCormack MC, McDonald MN, McEvoy CE, Moll M, Molye SS, Murray S, Nath H, Newell JD Jr, Occhipinti M, Paoletti M, Parekh T, Pistolesi M, Pratte KA, Putcha N, Ragland M, Reinhardt JM, Rennard SI, Rosiello RA, Ross JC, Rossiter HB, Ruczinski I, San Jose Estepar R, Sciurba FC, Sieren JC, Singh H, Soler X, Steiner RM, Strand MJ, Stringer WW, Tal-Singer R, Thomashow B, Vegas Sánchez-Ferrero G, Walsh JW, Wan ES, Washko GR, Michael Wells J, Wendt CH, Westney G, Wilson A, Wise RA, Yen A, Young K, Yun J, Silverman EK, Crapo JD.

Chronic Obstr Pulm Dis. 2019 Nov;6(5):384-399. doi: 10.15326/jcopdf.6.5.2019.0149.

6.

The Burden of Rural Chronic Obstructive Pulmonary Disease: Analyses from the National Health and Nutrition Examination Survey.

Raju S, Brigham EP, Paulin LM, Putcha N, Balasubramanian A, Hansel NN, McCormack MC.

Am J Respir Crit Care Med. 2020 Feb 15;201(4):488-491. doi: 10.1164/rccm.201906-1128LE. No abstract available.

PMID:
31644882
7.

Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.

Aboumatar H, Naqibuddin M, Chung S, Chaudhry H, Kim SW, Saunders J, Bone L, Gurses AP, Knowlton A, Pronovost P, Putcha N, Rand C, Roter D, Sylvester C, Thompson C, Wolff JL, Hibbard J, Wise RA.

JAMA. 2019 Oct 8;322(14):1371-1380. doi: 10.1001/jama.2019.11982.

PMID:
31593271
8.

Obstructive Sleep Apnea and Airway Dimensions in Chronic Obstructive Pulmonary Disease.

Koch AL, Brown RH, Woo H, Brooker AC, Paulin LM, Schneider H, Schwartz AR, Diette GB, Wise RA, Hansel NN, Putcha N.

Ann Am Thorac Soc. 2020 Jan;17(1):116-118. doi: 10.1513/AnnalsATS.201903-220RL. No abstract available.

PMID:
31425663
9.

Nanoparticle diffusion in spontaneously expectorated sputum as a biophysical tool to probe disease severity in COPD.

Chisholm JF, Shenoy SK, Shade JK, Kim V, Putcha N, Carson KA, Wise R, Hansel NN, Hanes JS, Suk JS, Neptune E.

Eur Respir J. 2019 Aug 1;54(2). pii: 1900088. doi: 10.1183/13993003.00088-2019. Print 2019 Aug.

PMID:
31164433
10.

Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study.

Maselli DJ, Bhatt SP, Anzueto A, Bowler RP, DeMeo DL, Diaz AA, Dransfield MT, Fawzy A, Foreman MG, Hanania NA, Hersh CP, Kim V, Kinney GL, Putcha N, Wan ES, Wells JM, Westney GE, Young KA, Silverman EK, Han MK, Make BJ.

Chest. 2019 Aug;156(2):228-238. doi: 10.1016/j.chest.2019.04.135. Epub 2019 May 30. Review.

PMID:
31154041
11.

Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD.

Lemoine S CM, Brigham EP, Woo H, Hanson CK, McCormack MC, Koch A, Putcha N, Hansel NN.

BMC Pulm Med. 2019 May 21;19(1):97. doi: 10.1186/s12890-019-0852-4.

12.

Chronic Obstructive Pulmonary Disease in America's Black Population.

Ejike CO, Dransfield MT, Hansel NN, Putcha N, Raju S, Martinez CH, Han MK.

Am J Respir Crit Care Med. 2019 Aug 15;200(4):423-430. doi: 10.1164/rccm.201810-1909PP. No abstract available.

PMID:
30789750
13.

Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS.

Putcha N, Fawzy A, Paul GG, Lambert AA, Psoter KJ, Sidhaye VK, Woo J, Wells JM, Labaki WW, Doerschuk CM, Kanner RE, Han MK, Martinez C, Paulin LM, Martinez FJ, Wise RA, O'Neal WK, Barr RG, Hansel NN; SPIROMICS investigators.

Ann Am Thorac Soc. 2018 Jun;15(6):710-717. doi: 10.1513/AnnalsATS.201708-687OC.

14.

Safety and Tolerability of Comprehensive Research Bronchoscopy in Chronic Obstructive Pulmonary Disease. Results from the SPIROMICS Bronchoscopy Substudy.

Wells JM, Arenberg DA, Barjaktarevic I, Bhatt SP, Bowler RP, Christenson SA, Couper DJ, Dransfield MT, Han MK, Hoffman EA, Kaner RJ, Kim V, Kleerup E, Martinez FJ, Moore WC, O'Beirne SL, Paine R 3rd, Putcha N, Raman SM, Barr RG, Rennard SI, Woodruff PG, Curtis JL.

Ann Am Thorac Soc. 2019 Apr;16(4):439-446. doi: 10.1513/AnnalsATS.201807-441OC.

PMID:
30653926
15.

Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study.

Fawzy A, Putcha N, Aaron CP, Bowler RP, Comellas AP, Cooper CB, Dransfield MT, Han MK, Hoffman EA, Kanner RE, Krishnan JA, Labaki WW, Paine R 3rd, Paulin LM, Peters SP, Wise R, Barr RG, Hansel NN; SPIROMICS Investigators.

Chest. 2019 Mar;155(3):519-527. doi: 10.1016/j.chest.2018.11.028. Epub 2018 Dec 26.

PMID:
30593776
16.

Asthma-Chronic Obstructive Pulmonary Disease Overlap: Diagnostic and Management Challenges.

Ohar J, Putcha N, Bradshaw M.

J Fam Pract. 2018 Oct;67(10 Suppl):S46-S51. No abstract available.

PMID:
30423011
17.

Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.

Aboumatar H, Naqibuddin M, Chung S, Chaudhry H, Kim SW, Saunders J, Bone L, Gurses AP, Knowlton A, Pronovost P, Putcha N, Rand C, Roter D, Sylvester C, Thompson C, Wolff JL, Hibbard J, Wise RA.

JAMA. 2018 Dec 11;320(22):2335-2343. doi: 10.1001/jama.2018.17933. Retraction in: JAMA. 2019 Oct 8;322(14):1417-1418.

18.

Occupational Exposures and Computed Tomographic Imaging Characteristics in the SPIROMICS Cohort.

Paulin LM, Smith BM, Koch A, Han M, Hoffman EA, Martinez C, Ejike C, Blanc PD, Rous J, Barr RG, Peters SP, Paine R 3rd, Pirozzi C, Cooper CB, Dransfield MT, Comellas AP, Kanner RE, Drummond MB, Putcha N, Hansel NN.

Ann Am Thorac Soc. 2018 Dec;15(12):1411-1419. doi: 10.1513/AnnalsATS.201802-150OC.

19.

Restrictive Spirometry and Cardiovascular Risk: Cause or Comorbidity?

Balasubramanian A, Putcha N.

Ann Am Thorac Soc. 2018 Oct;15(10):1142-1143. doi: 10.1513/AnnalsATS.201807-494ED. No abstract available.

PMID:
30272499
20.

Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS.

Ghosh S, Anderson WH, Putcha N, Han MK, Curtis JL, Criner GJ, Dransfield MT, Barr RG, Krishnan JA, Lazarus SC, Cooper CB, Paine R 3rd, Peters SP, Hansel NN, Martinez FJ, Drummond MB; Current and former investigators of the SPIROMICS sites and reading centers.

Ann Am Thorac Soc. 2019 Feb;16(2):200-208. doi: 10.1513/AnnalsATS.201804-283OC.

21.

Medication Regimens for Managing COPD Exacerbations.

Putcha N, Wise RA.

Respir Care. 2018 Jun;63(6):773-782. doi: 10.4187/respcare.05912. Review.

22.

Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS.

Putcha N, Paul GG, Azar A, Wise RA, O'Neal WK, Dransfield MT, Woodruff PG, Curtis JL, Comellas AP, Drummond MB, Lambert AA, Paulin LM, Fawzy A, Kanner RE, Paine R 3rd, Han MK, Martinez FJ, Bowler RP, Barr RG, Hansel NN; SPIROMICS investigators.

PLoS One. 2018 Apr 12;13(4):e0194924. doi: 10.1371/journal.pone.0194924. eCollection 2018.

23.

Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts.

Fawzy A, Putcha N, Paulin LM, Aaron CP, Labaki WW, Han MK, Wise RA, Kanner RE, Bowler RP, Barr RG, Hansel NN; SPIROMICS and COPDGene Investigators.

Respir Res. 2018 Jan 26;19(1):20. doi: 10.1186/s12931-018-0717-z.

24.

Neighbourhood characteristics and health outcomes: evaluating the association between socioeconomic status, tobacco store density and health outcomes in Baltimore City.

Galiatsatos P, Kineza C, Hwang S, Pietri J, Brigham E, Putcha N, Rand CS, McCormack M, Hansel NN.

Tob Control. 2018 Jul;27(e1):e19-e24. doi: 10.1136/tobaccocontrol-2017-053945. Epub 2017 Nov 23.

25.

Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.

Hastie AT, Martinez FJ, Curtis JL, Doerschuk CM, Hansel NN, Christenson S, Putcha N, Ortega VE, Li X, Barr RG, Carretta EE, Couper DJ, Cooper CB, Hoffman EA, Kanner RE, Kleerup E, O'Neal WK, Paine R 3rd, Peters SP, Alexis NE, Woodruff PG, Han MK, Meyers DA, Bleecker ER; SPIROMICS investigators.

Lancet Respir Med. 2017 Dec;5(12):956-967. doi: 10.1016/S2213-2600(17)30432-0. Epub 2017 Nov 13.

26.

Alveolar eosinophilia in current smokers with chronic obstructive pulmonary disease in the SPIROMICS cohort.

Martinez CH, Li SX, Hirzel AJ, Stolberg VR, Alexis NE, Barr RG, Bleecker ER, Carretta EE, Christenson SA, Cooper CB, Couper DJ, Doerschuk CM, Han MK, Hansel NN, Hastie AT, Hoffman EA, Kaner RJ, Martinez FJ, Meyers DA, O'Neal WK, Paine R 3rd, Putcha N, Rennard SI, Woodruff PG, Zeidler M, Curtis JL, Freeman CM; SPIROMICS Investigators.

J Allergy Clin Immunol. 2018 Jan;141(1):429-432. doi: 10.1016/j.jaci.2017.07.039. Epub 2017 Sep 12. No abstract available.

27.

Impact of Physical Activity on Reporting of Childhood Asthma Symptoms.

Nnodum BN, McCormack MC, Putcha N, Hwang S, Paulin LM, Brigham EP, Fawzy A, Romero K, Diette GB, Hansel NN.

Lung. 2017 Dec;195(6):693-698. doi: 10.1007/s00408-017-0049-7. Epub 2017 Sep 15.

28.

Better Respiratory Education and Treatment Help Empower (BREATHE) study: Methodology and baseline characteristics of a randomized controlled trial testing a transitional care program to improve patient-centered care delivery among chronic obstructive pulmonary disease patients.

Aboumatar H, Naqibuddin M, Chung S, Adebowale H, Bone L, Brown T, Cooper LA, Gurses AP, Knowlton A, Kurtz D, Piet L, Putcha N, Rand C, Roter D, Shattuck E, Sylvester C, Urteaga-Fuentes A, Wise R, Wolff JL, Yang T, Hibbard J, Howell E, Myers M, Shea K, Sullivan J, Syron L, Wang NY, Pronovost P; BREATHE Study Patient Family Partners Group.

Contemp Clin Trials. 2017 Nov;62:159-167. doi: 10.1016/j.cct.2017.08.018. Epub 2017 Sep 5.

PMID:
28887069
29.

Cigarette smoke disrupts monolayer integrity by altering epithelial cell-cell adhesion and cortical tension.

Nishida K, Brune KA, Putcha N, Mandke P, O'Neal WK, Shade D, Srivastava V, Wang M, Lam H, An SS, Drummond MB, Hansel NN, Robinson DN, Sidhaye VK.

Am J Physiol Lung Cell Mol Physiol. 2017 Sep 1;313(3):L581-L591. doi: 10.1152/ajplung.00074.2017. Epub 2017 Jun 22.

30.

Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD.

Lambert AA, Putcha N, Drummond MB, Boriek AM, Hanania NA, Kim V, Kinney GL, McDonald MN, Brigham EP, Wise RA, McCormack MC, Hansel NN; COPDGene Investigators.

Chest. 2017 Jan;151(1):68-77. doi: 10.1016/j.chest.2016.08.1432. Epub 2016 Aug 25.

31.

Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.

Dransfield MT, Kunisaki KM, Strand MJ, Anzueto A, Bhatt SP, Bowler RP, Criner GJ, Curtis JL, Hanania NA, Nath H, Putcha N, Roark SE, Wan ES, Washko GR, Wells JM, Wendt CH, Make BJ; COPDGene Investigators.

Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.

32.

Chronic respiratory disease and high altitude are associated with depressive symptoms in four diverse settings.

Zaeh S, Miele CH, Putcha N, Gilman RH, Miranda JJ, Bernabe-Ortiz A, Wise RA, Checkley W.

Int J Tuberc Lung Dis. 2016 Sep;20(9):1263-9. doi: 10.5588/ijtld.15.0794.

PMID:
27510256
33.

Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Nothing New Under the Sun.

Putcha N, Wise RA.

Immunol Allergy Clin North Am. 2016 Aug;36(3):515-28. doi: 10.1016/j.iac.2016.03.003. Review.

34.

Influence of Lung Function and Sleep-disordered Breathing on All-Cause Mortality. A Community-based Study.

Putcha N, Crainiceanu C, Norato G, Samet J, Quan SF, Gottlieb DJ, Redline S, Punjabi NM.

Am J Respir Crit Care Med. 2016 Oct 15;194(8):1007-1014.

35.

Agreement Between Results of Home Sleep Testing for Obstructive Sleep Apnea with and Without a Sleep Specialist.

Aurora RN, Putcha N, Swartz R, Punjabi NM.

Am J Med. 2016 Jul;129(7):725-30. doi: 10.1016/j.amjmed.2016.02.015. Epub 2016 Mar 8.

36.

Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort.

Putcha N, Barr RG, Han MK, Woodruff PG, Bleecker ER, Kanner RE, Martinez FJ, Smith BM, Tashkin DP, Bowler RP, Eisner MD, Rennard SI, Wise RA, Hansel NN; SPIROMICS Investigators.

Thorax. 2016;71:411-420. doi: 10.1136/thoraxjnl-2015-207487. Epub 2016 Mar 9.

37.

Association Between Expiratory Central Airway Collapse and Respiratory Outcomes Among Smokers.

Bhatt SP, Terry NL, Nath H, Zach JA, Tschirren J, Bolding MS, Stinson DS, Wilson CG, Curran-Everett D, Lynch DA, Putcha N, Soler X, Wise RA, Washko GR, Hoffman EA, Foreman MG, Dransfield MT; Genetic Epidemiology of COPD (COPDGene) Investigators.

JAMA. 2016 Feb 2;315(5):498-505. doi: 10.1001/jama.2015.19431.

38.

Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Putcha N, Drummond MB, Wise RA, Hansel NN.

Semin Respir Crit Care Med. 2015 Aug;36(4):575-91. doi: 10.1055/s-0035-1556063. Epub 2015 Aug 3. Review.

39.

Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea.

Mesarwi OA, Shin MK, Drager LF, Bevans-Fonti S, Jun JC, Putcha N, Torbenson MS, Pedrosa RP, Lorenzi-Filho G, Steele KE, Schweitzer MA, Magnuson TH, Lidor AO, Schwartz AR, Polotsky VY.

Sleep. 2015 Oct 1;38(10):1583-91. doi: 10.5665/sleep.5052.

40.

Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.

Putcha N, Han MK, Martinez CH, Foreman MG, Anzueto AR, Casaburi R, Cho MH, Hanania NA, Hersh CP, Kinney GL, Make BJ, Steiner RM, Lutz SM, Thomashow BM, Williams AA, Bhatt SP, Beaty TH, Bowler RP, Ramsdell JW, Curtis JL, Everett D, Hokanson JE, Lynch DA, Sutherland ER, Silverman EK, Crapo JD, Wise RA, Regan EA, Hansel NN; the COPDGene® Investigators.

Chronic Obstr Pulm Dis. 2014;1(1):105-114.

41.

Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease.

Paulin LM, Diette GB, Blanc PD, Putcha N, Eisner MD, Kanner RE, Belli AJ, Christenson S, Tashkin DP, Han M, Barr RG, Hansel NN; SPIROMICS Research Group.

Am J Respir Crit Care Med. 2015 Mar 1;191(5):557-65. doi: 10.1164/rccm.201408-1407OC.

42.

A simplified score to quantify comorbidity in COPD.

Putcha N, Puhan MA, Drummond MB, Han MK, Regan EA, Hanania NA, Martinez CH, Foreman M, Bhatt SP, Make B, Ramsdell J, DeMeo DL, Barr RG, Rennard SI, Martinez F, Silverman EK, Crapo J, Wise RA, Hansel NN.

PLoS One. 2014 Dec 16;9(12):e114438. doi: 10.1371/journal.pone.0114438. eCollection 2014.

43.

All-cause mortality in asthma. The importance of age, comorbidity, and socioeconomic status.

Putcha N, Hansel NN.

Ann Am Thorac Soc. 2014 Oct;11(8):1252-3. doi: 10.1513/AnnalsATS.201408-392ED. No abstract available.

44.

Indoor pollutant exposure is associated with heightened respiratory symptoms in atopic compared to non-atopic individuals with COPD.

Kaji DA, Belli AJ, McCormack MC, Matsui EC, Williams DL, Paulin L, Putcha N, Peng RD, Diette GB, Breysse PN, Hansel NN.

BMC Pulm Med. 2014 Sep 10;14:147. doi: 10.1186/1471-2466-14-147.

45.

Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index.

Frei A, Muggensturm P, Putcha N, Siebeling L, Zoller M, Boyd CM, ter Riet G, Puhan MA.

J Clin Epidemiol. 2014 Aug;67(8):904-11. doi: 10.1016/j.jclinepi.2014.03.005. Epub 2014 Apr 29.

46.

Chronic productive cough is associated with death in smokers with early COPD.

Putcha N, Drummond MB, Connett JE, Scanlon PD, Tashkin DP, Hansel NN, Wise RA.

COPD. 2014 Aug;11(4):451-8. doi: 10.3109/15412555.2013.837870. Epub 2013 Oct 15.

47.

Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008.

Putcha N, Puhan MA, Hansel NN, Drummond MB, Boyd CM.

COPD. 2013 Jun;10(3):324-32. doi: 10.3109/15412555.2012.744963.

48.

Biophysical responses upon the interaction of nanomaterials with cellular interfaces.

Wu YL, Putcha N, Ng KW, Leong DT, Lim CT, Loo SC, Chen X.

Acc Chem Res. 2013 Mar 19;46(3):782-91. doi: 10.1021/ar300046u. Epub 2012 Nov 29. Review.

PMID:
23194178
49.

Inhaled corticosteroids for people with chronic obstructive pulmonary disease are associated with an increased risk of fracture.

Putcha N, Drummond MB.

Evid Based Med. 2012 Jun;17(3):90-1. doi: 10.1136/ebm.2011.100221. Epub 2011 Oct 25. No abstract available.

PMID:
22028376
50.

Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials.

Tamma PD, Putcha N, Suh YD, Van Arendonk KJ, Rinke ML.

BMC Infect Dis. 2011 Jun 22;11:181. doi: 10.1186/1471-2334-11-181. Review.

Supplemental Content

Loading ...
Support Center